ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TSVT 2seventy bio Inc

4.7499
-0.1801 (-3.65%)
최종 업데이트: 00:57:39
15분 지연
기업명 주식 심볼 시장 주식 타입
2seventy bio Inc TSVT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.1801 -3.65% 4.7499 00:57:39
개장가 저가 고가 종가 전일 종가
4.93 4.71 5.1299 4.93
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202420:00BW2seventy bio to Report First Quarter 2024 Financial Results..
05/04/202422:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
01/04/202420:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
21/03/202406:04BW2seventy bio Announces Appointments of Eli Casdin and..
16/03/202407:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
08/03/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/03/202421:03EDGAR2Form 8-K - Current report
05/03/202421:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
01/03/202421:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
06/02/202406:05BW2seventy bio to Participate in Upcoming Investor Conferences
05/02/202421:02EDGAR2Form 8-K - Current report
05/02/202420:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
03/02/202406:54EDGAR2Form 8-K/A - Current report: [Amend]
30/01/202423:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30/01/202421:48EDGAR2Form 8-K - Current report
30/01/202421:01BW2seventy bio Announces New Strategic Path Forward
06/01/202406:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202321:25EDGAR2Form 8-K - Current report
12/12/202309:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
11/12/202321:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
07/12/202304:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
01/12/202320:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202320:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202320:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202320:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
21/11/202304:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
20/11/202322:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
20/11/202321:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
20/11/202321:20EDGAR2Form 8-K - Current report
20/11/202320:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
14/11/202321:00BW2seventy bio Reports Third Quarter Financial Results and..
10/11/202321:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
26/10/202320:05EDGAR2Form 8-K - Current report
14/09/202305:03EDGAR2Form 8-K - Current report
12/09/202320:13EDGAR2Form 8-K - Current report
12/09/202320:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
12/09/202319:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
07/09/202305:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/09/202320:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
17/08/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/08/202307:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/08/202309:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202320:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:02EDGAR2Form 8-K - Current report
14/08/202320:00BW2seventy bio Reports Second Quarter Financial Results and..
08/08/202320:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
02/08/202305:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
27/07/202322:16EDGAR2Form 8-K - Current report
14/06/202320:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
07/06/202320:00BW2seventy bio to Participate in Upcoming Investor Conference

최근 히스토리

Delayed Upgrade Clock